Peptides for Biohackers: What's Actually Evidence-Backed in the Longevity Space

How peptide Targets Peptides for Biohackers & Longevity Protocols

The longevity-peptide landscape has more advocacy than evidence. The honest framing for any of these compounds is that they sit somewhere on a spectrum from 'biologically interesting with thin clinical data' to 'biologically interesting with almost no human data'. None of them have completed a longevity-endpoint RCT in humans, because longevity-endpoint trials in humans are a multi-decade undertaking nobody has funded.

Closest to evidence-supported: GHK-Cu has decades of dermatology and wound-healing data. Its mechanism is real (modulates >4,000 genes), and the cosmetic translation is well-supported. Whether topical or systemic GHK-Cu produces measurable systemic longevity benefit is not established.

Reasonable mechanistic case, thin clinical data: Epitalon has the longest 'longevity peptide' history. Khavinson's group has published cohort data suggesting reduced mortality and cancer incidence in elderly Russian populations on cyclic Epitalon. External replication of those endpoints is essentially absent. Mechanistic premise (telomerase activation, melatonin restoration) is biologically plausible.

MOTS-c and the mitochondrial-derived peptide class have a 'metabolic flexibility' rationale grounded in mtDNA-encoded signaling. Most data is rodent. SS-31 (elamipretide) has more clinical depth in mitochondrial disease but isn't really studied in healthy adults pursuing longevity.

More speculative: FOXO4-DRI is a senolytic peptide with rodent evidence for selective elimination of senescent cells. There is no published human safety or efficacy trial. Use is exploratory.

Where biohackers most often go wrong: stacking 5+ peptides simultaneously and attributing every subjective change to the peptide stack rather than the diet, sleep, and training shifts that usually accompany the experiment. Simple protocols with one variable at a time generate interpretable data; complex stacks generate stories.